Search - tctmd.com

Displaying 161 - 180 of 345

Sort: Relevancy | Date

News Industry News

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

December 15, 2015

News Industry News

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

December 08, 2015

News Daily News

低流量、低跨瓣压差患者死亡率较高，接受 AVR 可能性较低

L.A. McKeown

December 07, 2015

News Daily News

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

L.A. McKeown

December 07, 2015

News Daily News

Los Pacientes de Flujo y Gradiente Bajos son Más Propensos a Morir y Menos a someterse a la Sustitución de la Válvula Aórtica

L.A. McKeown

December 07, 2015

Presentation

Outcome and Impact of AVR in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis (AS)

Presenter: V. Dayan

December 06, 2015

News Daily News

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Yael L. Maxwell

November 24, 2015

News Industry News

Leviticus Cardio Achieves Successful Transcutaneous Coplanar Energy Transfer in Chronic Animal Model

November 15, 2015

News Daily News

TAVR 后心肌损伤与死亡率挂钩

Caitlin E. Cox

November 02, 2015

News Daily News

Post-TAVR Myocardial Injury Linked to Mortality

Caitlin E. Cox

November 02, 2015

News Daily News

Las Lesiones Miocárdica Post-TAVR se asocian a la Mortalidad

Caitlin E. Cox

November 02, 2015

Presentation

LVAD Therapy in End-Stage Heart Disease

Presenter: Matthias Loebe

October 30, 2015

News Industry News

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

October 26, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

News Conference News TCT 2015

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Todd Neale

October 13, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

News Industry News

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

October 12, 2015

News Daily News

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

October 01, 2015

News Daily News

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

October 01, 2015

Advertisement

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

低流量、低跨瓣压差患者死亡率较高，接受 AVR 可能性较低

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

Los Pacientes de Flujo y Gradiente Bajos son Más Propensos a Morir y Menos a someterse a la Sustitución de la Válvula Aórtica

Outcome and Impact of AVR in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis (AS)

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Leviticus Cardio Achieves Successful Transcutaneous Coplanar Energy Transfer in Chronic Animal Model

TAVR 后心肌损伤与死亡率挂钩

Post-TAVR Myocardial Injury Linked to Mortality

Las Lesiones Miocárdica Post-TAVR se asocian a la Mortalidad

LVAD Therapy in End-Stage Heart Disease

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

在采用TAVR的早期，在试验中心以外接受治疗的患者的死亡率并非更高

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content